NLRP3 and breast cancer: In addition, it is still questionable whether there is a correlation between PI3K/AKT, CALR/NLRP3/IL-1β, and MMP/sPD-L1/PD-L1 and cyclin D/CDK4,6 in PBMCs of BC patients.